Putative Mechanisms of Action of Endobronchial Coils
To the Editor:
Chronic obstructive pulmonary disease is a progressive disease characterized by flow limitation, perceived most commonly as dyspnea (1) . Although bronchodilators, still the cornerstone of end-stage treatment, quite often are found inadequate to alleviate patients' symptoms, new procedures have been developed, including surgical techniques such as lung volume reduction surgery targeted to reduce resting hyperinflation and its static and dynamic components (2) . The procedure improved elastic recoil, enhanced the radial traction of the airways, and finally increased conductance and expiratory flows (3). Bronchoscopic lung volume reduction methods are emerging as a viable alternative to lung volume reduction surgery (4) (5) (6) (7) (8) (9) . Endobronchial valves are most effective when they result in significant lung volume reduction by inducing atelectasis (4) . Previous studies highlighted the safety and efficacy profile of the lung volume reduction coils (LVRCs) (5) (6) (7) (8) (9) . In contrast, the mechanism of action of the procedure remains unclear. Recently, the RESET (Endobronchial Coils for the Treatment of Emphysema with Hyperinflation; ClinicalTrials.gov NCT01334307) trial concluded that there were no changes in total lung capacity (TLC) (5) and supported that the radial traction exerted by the LVRC created volume reduction in the targeted lung areas and tethered open the small airways (5, 9) . To examine further the effects of LVRC, we have performed a more detailed analysis of the pulmonary function data obtained from a large subset of the patients in the RESET study and correlated them with changes in lobar lung volumes and emphysema scores obtained from computerized tomography (CT) scans.
Methods
The design, methods, and primary data of the RESET study have been published previously (5) . This further analysis is based on the subgroup of patients enrolled only at the Royal Brompton and Harefield National Health Service Hospital Trust in a one-to-one Figure 2 . The effect of inhaled allergen on (A) B-cell activating factor (BAFF), specific IgE, and total IgE levels in sputum fluid phase measured at baseline and again at 7 and 24 hours after challenge (n = 7 subjects) and (B) specific IgE and total IgE levels in blood measured at baseline and until 28 days after challenge (n = 12 subjects). Data are presented as means 6 SEM. Significant findings are denoted by an asterisk, where P , 0.05 compared with prechallenge baseline.
Author Contributions: The protocol was developed by P.L.S.; the software for lung volume measurement on computerized tomography scanning was developed by M.S. and G.-Z.Y.; the first draft of the paper was written by A.F.P. and P.L.S.; all authors contributed to the recruitment of patients and collection of data; all authors contributed to data interpretation and subsequent revisions; and the final version submitted was approved by all authors.
ratio to either LVRC treatment (18 patients) or best medical care (18 patients). All patients were receiving optimal medication, according to the current guidelines (1), and completed a rehabilitation program within 6 months. The two groups were well matched. Lung function tests were conducted according to the American Thoracic Society guidelines (10) . Imaging data were obtained from high-resolution CT scans with the patients in full inspiration (SOMATOM Definition AS and Sensation 64; Siemens Medical, Erlangen, Germany; Table 1 ). Data were reconstructed to provide overlapping 6-mm thick slices every 3 mm for in-depth analysis. We used a customized image processing program written in the matrix laboratory software (MATLAB; Mathworks, Natick, MA) for computing CT lung volumes and emphysema scores (i.e., the percentage of lung tissue below 2950 Hounsfield units). The program was developed by the Hamlyn Centre for Robotic Surgery at Imperial College London, London, United Kingdom, and could automatically segment the lungs and the airways. The program also automatically discarded the coils from any density measurements. The lobar segmentation was semiautomatically performed (10-13).
The lobar volume and percentage of emphysema scoring was performed on 14 patients in each group. All assessments were performed at baseline and 3 months after the final treatment (Table 1) .
Statistics
Statistical significance of the change in lung function, CT lung volumes, and emphysema scores at baseline and 3 months after the procedures was computed with the paired t test. Pearson's correlation coefficient, and regression analyses were used to assess relationships between variables. All statistical analyses were performed with SigmaStat and SigmaPlot v.10 (Systat Software, Inc., San Jose, CA), and P , 0.05 was considered statistically significant.
Results
There was a reduction in volume by 360 ml in the treatment lobes. In contrast, there were no improvements in the targeted lobes in the control group. The emphysema scores were significantly improved in the treatment lobes (D: 16.3% below 2950 Hounsfield units), but the targeted lobes remained unchanged in the control group (Table 1) .
Significant improvements were observed in FEV 1 , FVC, and residual volume (RV) in the LVRC treatment group. The results suggested similar improvements in FRC, inspiratory capacity (IC), residual volume-TLC ratio (RV/TLC), and IC-TLC ratio in the LVRC group (Table 1) . Of greater interest were the improvements in specific airway conductance (sGaw) in the treatment group. In contrast, there was a deterioration in the control group. Although there was no appreciable change in airway resistance in the treatment group, the between-group differences were statistically significant (Table 1) .
Further analysis revealed that the volume change in the treatment lobes correlated with the DRV (r = 0.564, P = 0.0358) and DFRC (r = 0.578, P = 0.0305) ( Figure 1A ). Change in the treatment lobes emphysema score also correlated with DFRC (r = 0.616, P = 0.0190), and DIC/TLC (r = 20.554, P = 0.0398) (Figure 2A ). Conversely, any correlations between the change in the untreated lobes volumes, emphysema scores, and lung function indices were not obtained ( Figures 1B and 2B ). Backward stepwise regression finally revealed significant correlations between the change in the treatment volume and DsGaw (P = 0.042) and DRV (P = 0.006).
Discussion
The novel findings of this randomized trial confirm that treatment with LVRC reduced the volume and the emphysema score at the treatment lobes. Finally, the sGaw improved after the procedure and correlated with the change of the volume in the treatment lobes (Table 1) .
Physiological techniques can only measure whole lung volumes, thus considering the lungs as a single unit (10) . However, this may not be appropriate in diseases in which the lungs are affected in a heterogeneous distribution or for which targeted treatment is available. This study observed for the first time through CT analysis a 360-ml reduction in treatment lobe volume with endobronchial coils in relation to controls. Conversely, the total lung volume with CT assessments and the TLC by plethysmography were matched without changing significantly after the therapy. The reason for this discrepancy was that the volume of the nontreatment lobes increased over the course of follow-up. This functional volume reduction correlated closely with the FRC and RV reduction, signaling possibly a restriction of inflation, and thus a drop in hyperinflation (14, 15) , of the emphysema-damaged lung areas. Furthermore, the volume reduction of the emphysematous treated areas could improve lung compliance by placing the lung in a sharper part of the pressure volume curve and put the diaphragm in a better condition of function with, as a consequence, an increase in driving pressure of the expiratory flows (16, 17) .
Previous studies have established the value of high-resolution CT to objectively quantify emphysema severity (10-13). The present study showed significant reductions of the treated lobe emphysema score in the treatment group. The reduction of the emphysema score was closely correlated with the FRC and IC/TLC, which probably represents less inflation of the already diseased areas. The implanted coils could compress the diseased lung parenchyma by winding it up around the site of their insertion. These compressed portions, although still diseased parenchymal sites, are identified in the CT scan as reduced emphysema score areas. The compressed areas are possibly less hyperinflated and simultaneously better transmit the elastic recoil pressure, thus improving airway tethering and interdependance (10) .
In addition to the loss of the lung compliance, elastic recoil, and airway radial traction, emphysematous airflow limitation is finally determined by the increased airway resistance (16, 17) . The data in this study (Table 1 ) confirmed a decrease in airway resistance and an increase in the specific airway conductance that was correlated with the volume reduction change in the treated lobes. Because sGaw mainly depends on the lungs' elastic properties, these findings could support the hypothesis that there is an increase in the diameter of the obstructed airways and a "holding the airways open" mechanism that can even facilitate lung emptying (18) (19) (20) .
A major limitation of our study is the sample size, which is small to redraw safe conclusions concerning the exact mechanism of the procedure. The lack of direct measurements of the lungs' elastic properties, and the absence of regional measurements concerning airway resistance and specific airway conductance of the treatment lobes, is another limitation. Deterioration observed in the control group spirometry and CT features can be attributed to disease progression, as these patients were all suffering from end-stage chronic obstructive pulmonary disease.
LVRC is a promising technique that reduces treatment lobar volumes and emphysema score and improves lung function. The findings are suggestive of a reduction in static hyperinflation and improvements in the lung elastic recoil and small airway 
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Control ( n =
Between Groups t Test at the treatment lobes with LVRC; EMPH untreated = emphysema score after masking at the untreated lobes; IC = inspiratory capacity; LVRC = lung volume reduction coil; Pretest P = covariate of linear regression for pretest and control groups; Raw In = inspiratory resistance; Raw Ex = expiratory resistance; RV = residual volume; sGaw In = inspiratory special conductance; sGaw Ex = expiratory special conductance; TLC = total lung capacity; V total = total volume of both lungs; V treatment = volume at the lobes treated with the LVRC; V untreated = volume at the lobes not treated with LVRC. Values are mean 6 SD unless otherwise specified.
Δ VOLUME TREATMENT LOBES (L) Although the data were interesting, we think the result for the association of the FEV 1 /FVC ratio at 7 years with ACOS is biased as a result of data sparsity. As a golden rule, to estimate logistic regression model parameters, a group that has a substantial fraction of the sample and adequate information should be considered as a reference group. Otherwise, the estimated regression coefficient will have a large SD (2). In the study conducted by Bui and colleagues (1), the first quartile of FEV 1 /FVC% predicted at 7 years with 39 patients with ACOS was compared with the highest (fourth) quartile with 3 patients with ACOS, so the value of the OR is inflated, and its confidence intervals are too wide. This phenomenon is called sparse data bias.
Using data presented in Bui and colleagues' We thank Erfan Ayubi and Saeid Safiri for their letter commenting on our article (1) [this issue, pp. 39-46] and drawing our attention to an alternative method of analysis.
We agree with the authors that the small number of asthma-chronic obstructive pulmonary disease overlap syndrome cases in the fourth quartile of FEV 1 /FVC may have biased the odds ratio (OR). We have redone the analysis, using both the Firth logistic regression (2) and the suggested penalized logistic regression with data augmentation (3). For Firth logistic regression, we got an OR of 13.3 (95% confidence interval, 4.2-42; P , .001). For penalized logistic regression with data augmentation, we obtained a slightly smaller OR (9.8) and tighter confidence interval (4.5-22.6; P , 0.001). Although OR was attenuated, our conclusions remain valid.
We note, however, that our recalculated OR is different from that calculated by the authors. The difference may be partly a 
